MARKET

PTE

PTE

Polarityte
NASDAQ
0.7855
-0.0445
-5.36%
After Hours: 0.7860 +0.0005 +0.06% 18:54 02/03 EST
OPEN
0.8300
PREV CLOSE
0.8300
HIGH
0.8400
LOW
0.7813
VOLUME
60.02K
TURNOVER
0
52 WEEK HIGH
13.00
52 WEEK LOW
0.6130
MARKET CAP
5.70M
P/E (TTM)
-0.1862
1D
5D
1M
3M
1Y
5Y
Northland Capital Markets Maintains Outperform Rating for PolarityTE: Here's What You Need To Know
Benzinga · 12/28/2022 17:00
Northland Capital Markets Maintains Outperform on PolarityTE, Lowers Price Target to $1
Benzinga · 12/28/2022 16:06
--Northland Securities Adjusts Price Target on PolarityTE to $1 From $1.25, Maintains Outperform Rating
--Northland Securities Adjusts Price Target on PolarityTE to $1 From $1.25, Maintains Outperform Rating
MT Newswires · 12/28/2022 10:55
PolarityTE stock jumps 10% on LOI for $7.5M buyout by shareholder Brauser
Seekingalpha · 12/27/2022 14:57
BRIEF-Polarityte Announces Entry Into A Letter Of Intent For Acquisition Of Company
Reuters · 12/27/2022 14:03
PolarityTE Announces Entry Into A Letter Of Intent With Michael Brauser For Him To Make An Offer To Acquire 100% Outstanding Equity Interests At Proposed Offering Price Of $1.03/Share
Benzinga · 12/27/2022 13:35
PolarityTE Says It Signed Tentative Agreement to Be Acquired
PolarityTE Says It Signed Tentative Agreement to Be Acquired
MT Newswires · 12/27/2022 09:33
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Investor Place · 11/14/2022 12:35
More
About PTE
PolarityTE, Inc. is a biotechnology company. The Company is focused on developing regenerative tissue products and biomaterials. It also operates a laboratory testing and clinical research business using equipment, personnel, and facilities it acquired to advance its development of regenerative tissue products. Its first regenerative tissue product is SkinTE, which is intended for the repair, reconstruction, replacement, and supplementation of skin in patients who have a need for treatment of acute or chronic wounds, burns, surgical reconstruction events, scar revision, or removal of dysfunctional skin grafts. The Company's development projects include SkinTE Cryo, SkinTE point-of-care device, PTE 11000, and others.

Webull offers kinds of Polarityte Inc stock information, including NASDAQ:PTE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PTE stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PTE stock methods without spending real money on the virtual paper trading platform.